Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. Oncology Institute Francisco Gentil

Claim This Site
Are you the site administrator? Claim this site to update information.
Basic Information
Site Overview
The Oncology Institute Francisco Gentil (popularly known as IPO Lisboa) is a highly prestigious public hospital and research center founded on December 29, 1923, as the country’s first comprehensive cancer center. As the primary oncology hub for southern Portugal, the facility manages highly specialized oncology healthcare for a population of nearly five million inhabitants spanning Greater Lisbon, Ribatejo, Alentejo, Algarve, and the autonomous regions of Azores and Madeira. Affiliated with the Portuguese National Health Service (SNS), IPO Lisboa is globally recognized for its pioneering contributions to clinical trials, basic and translational oncology research, its compassionate "patient-first" humanistic care philosophy, and its historical milestone of introducing the region's first structured palliative care and patient residential support infrastructure.
Business Status
Business Category
Business Subcategory
Conditions
Sponsors
Facilities & Operations
Facilities and operational capabilities inferred from trial participation
Research Technology
Research technology inferred from trial participation
Imaging & Diagnostics
Imaging and diagnostic capabilities inferred from trial participation
Laboratory & Biospecimens
Laboratory and biospecimen capabilities inferred from trial participation
Research Pharmacy & Investigational Product
Investigational-product capabilities inferred from trial participation
Clinical Procedures
Clinical procedures inferred from trial participation
Accessibility & Parking
Accessibility Features
Additional Capabilities
Other capabilities inferred from trial participation